Liver Health Checks: Current Tests, Emerging Screening Tools, and who may Benefit from Assessment
Why liver health matters
Your liver quietly performs hundreds of essential functions, including processing nutrients, filtering toxins, regulating cholesterol, and supporting blood clotting. Many liver conditions develop gradually and may not cause symptoms in early stages.
Liver health checks aim to detect inflammation, fat accumulation, or scarring (fibrosis) before complications occur. The goal is early risk identification and appropriate follow-up, not unnecessary labelling.
What standard liver tests assess
In general practice, assessment usually begins with blood tests often called liver function tests (LFTs). These measure enzymes and proteins such as ALT, AST, ALP, GGT, bilirubin, and albumin.
Raised enzyme levels may reflect liver irritation or injury, although mild abnormalities can occur for many reasons and do not automatically indicate serious disease.
Depending on your history, your GP may also assess:
Viral hepatitis status
Cholesterol and glucose levels
Markers of metabolic risk
Clotting function
An abdominal ultrasound is commonly used to detect fatty liver change or structural abnormalities.
Non-invasive fibrosis assessment
Modern liver care increasingly relies on non-invasive tools to estimate scarring without biopsy.
Fibrosis scores
Tools such as the FIB-4 index combine age and routine blood results to estimate the likelihood of advanced fibrosis. These scores help identify who needs further investigation and who can be safely monitored in primary care.
Liver stiffness measurement
Transient elastography (commonly known as FibroScan) measures liver stiffness through a probe placed on the skin. Increased stiffness often correlates with fibrosis.
This test is painless, quick, and widely used in specialist and some community settings.
Emerging and evolving technologies
Liver diagnostics continue to evolve. Newer developments include:
Advanced biomarker panels designed to reflect fibrosis activity
MRI-based measurements that quantify liver fat and stiffness with greater precision
Research into AI-assisted imaging interpretation
Novel blood markers linked with fibrotic activity
Access and suitability vary across Australia. These technologies complement, rather than replace, clinical assessment.
Who may benefit from assessment
Routine screening for the entire population is not recommended. Assessment is usually targeted toward individuals with higher risk.
You may benefit from liver evaluation if you have:
Type 2 diabetes
Obesity or central weight gain
Elevated cholesterol or metabolic syndrome
Regular alcohol intake
Chronic hepatitis B or C
A family history of liver disease
Long-term use of certain medications
Liver cancer surveillance is also recommended in specific high-risk groups, particularly those with cirrhosis or chronic viral hepatitis.
Your GP considers your overall health profile rather than relying on a single test result.
How to interpret results sensibly
Liver tests require context. A mildly abnormal result does not confirm severe disease, and a normal result does not exclude all risk.
Follow-up decisions depend on patterns over time, risk factors, symptoms, and imaging findings. Often, lifestyle modification plays a central role in preventing progression of metabolic liver disease.
A calm, structured conversation with your GP helps translate numbers into meaningful action.
This article provides general health information only and does not replace medical advice. Please speak with your GP for personalised care.